Latest News and Press Releases

Pratteln, Schweiz, 1. März 2021 - Santhera Pharmaceuticals (SIX: SANN) gibt positive Ergebnisse der Phase-1b-Dosis-Eskalationsstudie mit Lonodelestat, einem potenten Inhibitor der humanen neutrophilen...

Pratteln, Switzerland, March 1, 2021 – Santhera Pharmaceuticals (SIX: SANN) announces positive results from its multiple ascending dose Phase 1b study with lonodelestat, a potent inhibitor of human...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. Pratteln, Schweiz, 24. Februar 2021 – Santhera Pharmaceuticals...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. Pratteln, Switzerland, February 24, 2021 – Santhera...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. Erwartung pivotaler 6-Monats-Daten für Vamorolone in...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. Pivotal 6-month data readout for vamorolone in Duchenne muscular...

Pratteln, Schweiz, 5. Februar 2021 – Santhera Pharmaceuticals (SIX: SANN) gibt die Ausgabe von 1‘600‘000 Vorratsaktien bekannt. Die Anzahl der im Handelsregister eingetragenen Aktien beträgt neu...

Pratteln, Switzerland, February 5, 2021 – Santhera Pharmaceuticals (SIX: SANN) announces that it has issued 1,600,000 treasury shares. The number of shares recorded in the commercial register has been...

Pratteln, Schweiz, 25. November 2020 – Santhera Pharmaceuticals (SIX: SANN) gibt die Ausgabe von 937‘928 Vorratsaktien bekannt. Die Anzahl der im Handelsregister eingetragenen Aktien beträgt neu...

Pratteln, Switzerland, November 25, 2020 – Santhera Pharmaceuticals (SIX: SANN) announces that it has issued 937,928 treasury shares. The number of shares recorded in the commercial register has been...